Affymetrix (AFFX) Cash Flow Statement

Click line-items for a historical chart and %

Net loss	10.11M
Depreciation and amortization	21.84M
Share-based compensation
Unrealized gain on hedging instruments
Realized gain on debt and equity investments	-1.38M
Other-than-temporary-impairment on non-marketable securities
Deferred tax assets
Amortization of debt offering costs
Gains from repurchase of convertible notes
Gain on disposal of property and equipment
Impairment of property and equipment
Accounts receivable, net	-11.98M
Inventories	-1.06M
Prepaid expenses and other assets	1.49M
Accounts payable and accrued liabilities	2.41M
Deferred revenue	-1.09M
Other long-term liabilities	871K
Net cash provided by operating activities
Capital expenditures	-10.46M
Purchases of available-for-sale securities
Proceeds from sales of available-for-sale securities	0
Proceeds from maturities of available-for-sale securities
Proceeds from sale of property and equipment	0
Purchase of technology rights	-533K
Net cash (used in) provided by investing activities	-73.17M
Issuance of common stock, net
Repurchase of convertible notes	0
Net cash used in financing activities	46.15M
Effect of exchange rate changes on cash and cash equivalents	-670K
Net (decrease) increase in cash and cash equivalents	8.84M
Cash and cash equivalents at beginning of period	79.92M
Cash and cash equivalents at end of period	88.77M

Entities mentioned with AFFX

View All Entities